145 related articles for article (PubMed ID: 28240665)
1. FDG PET to Diagnose Neurolymphomatosis in a Case of Triple-Hit B-Cell Lymphoma.
Bund C; Heimburger C; Trensz P; Fohrer C; Kremer S; Namer IJ
Clin Nucl Med; 2017 Jun; 42(6):458-460. PubMed ID: 28240665
[TBL] [Abstract][Full Text] [Related]
2. FDG PET/CT in Pediatric Neurolymphomatosis.
de Vaugelade C; de Clermont-Gallerande H; Meyer M; My Duyen Tiphaine A; Benjamin A; Ducassou S; Chateil JF; Fernandez P
Clin Nucl Med; 2017 May; 42(5):e255-e257. PubMed ID: 28288046
[TBL] [Abstract][Full Text] [Related]
3. FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes.
Davidson T; Kedmi M; Avigdor A; Komisar O; Chikman B; Lidar M; Goshen E; Tzila Zwas S; Ben-Haim S
Leuk Lymphoma; 2018 Feb; 59(2):348-356. PubMed ID: 28750592
[TBL] [Abstract][Full Text] [Related]
4. Fluorothymidine PET/CT in neurolymphomatosis.
Biswal CK; Mittal BR; Shukla J; Vatsa R; Bhattacharya A; Prabhakar S
Clin Nucl Med; 2015 May; 40(5):e290-2. PubMed ID: 25546221
[TBL] [Abstract][Full Text] [Related]
5. Neurolymphomatosis: MRI and (18) FDG-PET features.
Lim AT; Clucas D; Khoo C; Parameswaran BK; Lau E
J Med Imaging Radiat Oncol; 2016 Feb; 60(1):92-5. PubMed ID: 25974748
[TBL] [Abstract][Full Text] [Related]
6. B-cell peripheral neurolymphomatosis: MRI and
DeVries AH; Howe BM; Spinner RJ; Broski SM
Skeletal Radiol; 2019 Jul; 48(7):1043-1050. PubMed ID: 30666391
[TBL] [Abstract][Full Text] [Related]
7. Diffuse Large B-Cell Lymphoma Recurring as Neurolymphomatosis on FDG PET/CT.
Ganeshalingam R; Roach P; Schembri GP
Clin Nucl Med; 2019 Feb; 44(2):145-147. PubMed ID: 30516683
[TBL] [Abstract][Full Text] [Related]
8. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound.
von Falck C; Rodt T; Joerdens S; Waldeck S; Kiesel H; Knapp WH; Galanski M
Clin Nucl Med; 2009 Aug; 34(8):493-5. PubMed ID: 19617723
[TBL] [Abstract][Full Text] [Related]
9. [A case of neurolymphomatosis diagnosed with FDG-PET].
Hoshikawa Y; Oguri T; Hattori M; Uematsu N; Matsukawa N; Yamawaki T; Kusumoto S; Ojika K
Rinsho Shinkeigaku; 2007 Jul; 47(7):437-40. PubMed ID: 17710889
[TBL] [Abstract][Full Text] [Related]
10. Neurolymphomatosis diagnosed by (18)F-FDG PET-CT.
Salm LP; Van der Hiel B; Stokkel MP
Clin Nucl Med; 2013 Jun; 38(6):e261-2. PubMed ID: 22996248
[TBL] [Abstract][Full Text] [Related]
11. [Neurolymphomatosis due to enteropathy-associated T-cell lymphoma clinically diagnosed by FDG-PET/CT and subsequently confirmed by autopsy].
Uematsu N; Sumi M; Kaiume H; Takeda W; Kirihara T; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H
Rinsho Ketsueki; 2018; 59(1):69-74. PubMed ID: 29415941
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of nasal type NK/T cell lymphoma presenting as neurolymphomatosis on 18F-FDG PET/CT: A case report and literature review.
Pan Q; Luo Y
Medicine (Baltimore); 2020 Jan; 99(1):e18640. PubMed ID: 31895825
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases.
Kinoshita H; Yamakado H; Kitano T; Kitamura A; Yamashita H; Miyamoto M; Hitomi T; Okada T; Nakamoto Y; Sawamoto N; Takaori-Kondo A; Takahashi R
J Neurol; 2016 Sep; 263(9):1719-26. PubMed ID: 27286845
[TBL] [Abstract][Full Text] [Related]
14. Neurolymphomatosis as a late relapse of non-Hodgkin's lymphoma detected by 18F-FDG PET/CT: a case report.
Kajáry K; Molnár Z; Mikó I; Barsi P; Lengyel Z; Szakáll S
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):39-42. PubMed ID: 23683830
[TBL] [Abstract][Full Text] [Related]
15. An Extremely Rare Intersection: Neurolymphomatosis in a Patient with Burkitt Lymphoma Detected by 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Oner AO; Okuyucu K; Alagoz E; Battal B; Arslan N
World J Nucl Med; 2016 Sep; 15(3):209-11. PubMed ID: 27651745
[TBL] [Abstract][Full Text] [Related]
16. Sacral nerve root neurolymphomatosis diagnosed on FDG-PET/CT and magnetic resonance imaging.
Dong Q; Wong KK; Avram AM
Clin Nucl Med; 2008 Jan; 33(1):30-1. PubMed ID: 18097253
[TBL] [Abstract][Full Text] [Related]
17. Neurolymphomatosis--diagnosis and assessment of treatment response by FDG PET-CT.
Lin M; Kilanowska J; Taper J; Chu J
Hematol Oncol; 2008 Mar; 26(1):43-5. PubMed ID: 17957824
[TBL] [Abstract][Full Text] [Related]
18. PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis.
Kanter P; Zeidman A; Streifler J; Marmelstein V; Even-Sapir E; Metser U; Stein GY; Cohen AM
Eur J Haematol; 2005 Jan; 74(1):66-9. PubMed ID: 15613109
[TBL] [Abstract][Full Text] [Related]
19. Chimeric Antigen Receptor T-Cell Therapy of Neurolymphomatosis Monitored by FDG PET/CT.
Li S; Wang H; Wang G; Lu X; Yang J
Clin Nucl Med; 2023 May; 48(5):445-447. PubMed ID: 36716490
[TBL] [Abstract][Full Text] [Related]
20. Bilateral primary renal lymphoma in a pediatric patient: staging and response evaluation with ¹⁸F-FDG PET/CT.
Dhull VS; Mukherjee A; Karunanithi S; Durgapal P; Bal C; Kumar R
Rev Esp Med Nucl Imagen Mol; 2015; 34(1):49-52. PubMed ID: 25065972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
